"
Team:Edinburgh/Interview Analysis
From 2011.igem.org
(→Media interaction) |
(→Patents) |
||
| Line 68: | Line 68: | ||
===Patents=== | ===Patents=== | ||
| + | |||
| + | Two interviewees mentioned gene patents as a potential problem. One was concerned about how patents are often used to prevent rival businesses from going ahead with their plans. Another mentioned the difficulties a small country has in dealing with patent issues, and mentioned the need for a unified approach in the European Union. | ||
==Sustainability== | ==Sustainability== | ||
Revision as of 15:17, 15 September 2011
Interview Analysis
During our interviews, a number of themes came up. Some related specifically to our biorefineries project, while others applied to synthetic biology more generally.
Contents |
Biosafety
Precautionary Principle
A number of interviewees mentioned the Precautionary Principle, which states that we should not do something unless we understand things well enough to know that it is safe. The Principle demands that anyone undertaking research show that it is not harmful.
Regulation
Some interviewees wanted to see greater regulation; for example by requiring stricter containment facilities for genetic engineering labs. There was a general acceptance of the need to strike a balance between regulation and allowing research to go forward.
One of our interviewees took the view that it was best to be on the leading edge of research, as this would help us prepare for bioterrorism or bioaccident.
We wondered whether tough regulation would lead to research going abroad, but one of our interviewees suggested that in some areas the UK government has to take a stand that something isn't acceptable, and if the result is research going abroad then so be it.
Accidental release
The accidental release of organisms into the environment was a concern of several interviewees. One pointed out that humanity has a dismal record of releasing alien species into the environment, leading to drastic ecological damage.
Another said that, when an organism is used on an industrial scale, release is inevitable. This implies that we must ensure an organism is safe; we can't rely on containment working (but this is not a reason to be lax in our containment efforts!)
Risk Assessments
The need for risk assessments was made clear by several interviewees. Of course, these already exist; our own project was subjected to a risk assessment.
Social justice
Who benefits?
Several interviewees were concerned that new technologies, including synthetic biology, would be used as tools for the rich to exploit the poor. "The rich" could mean either rich corporations, or rich nations.
Exploitation / sourcing
This was particularly relevant to our project, since a biorefinery would require large amounts of feedstock. While ideally such feedstock would be mere waste, some interviewees questioned the plausibility of this. We must avoid a situation where land is diverted from food production for the sake of producing crops that are turned into high fructose corn syrup or ethanol for the rich.
Other ethical questions
Animal suffering
A couple of interviewees mentioned this as a specific concern. It is not relevant to projects involving bacteria, but in the future it will become easier to modify animals. Where this is for research, we must ensure that suffering is minimised, and if it is ever done for purely aesthetic reasons (e.g. GloFish) then we ought to ensure there is no suffering at all.
One interviewee pointed out that genetic modification of animals is strictly regulated in the UK.
Other disciplines
One interviewee pointed out that biologists are not trained ethicists, and emphasised the need for involvement of people of other fields. Another pointed out that "human practices" has always been a key part of the synthetic biology community - for example at conferences, it is always a major subject for discussion.
Democracy
Public engagement
Several interviewees stressed the need for open debate and public engagement. This is true at two levels: the level of society, where a broad scale debate must take place, but also the level of local communities, where biorefineries will be placed or crops will be grown.
There is a need for consultation, and projects must not go ahead without the consent of the people affected.
Media interaction
One interviewee criticised media reporting of GM foods. In general, the interviewees stressed the need for the public to be well-informed of what is going on; naturally this requires accurate reporting in the press.
Patents
Two interviewees mentioned gene patents as a potential problem. One was concerned about how patents are often used to prevent rival businesses from going ahead with their plans. Another mentioned the difficulties a small country has in dealing with patent issues, and mentioned the need for a unified approach in the European Union.
